|
In
the News
“Methadonia:
America
Undercover” (9/24/2005)
AAAP Membership Committee Chairman Laurence M.
Westreich, MD, attended the September 24th
premiere of “Methadonia,” an 88 minute
documentary film directed by Michel Negroponte.
The film was shown at the New York Film Festival
and documents several months in the lives of some
patients in an outpatient group for addicts in a
New York City
treatment center.
The
House of Representatives voted 429-0 to approve S.
45 (7/27/2005)
The
House of Representatives voted 429-0 to approve S.
45, the Drug Abuse Treatment Expansion Act, the
Senate-passed companion legislation to H.R.
869.
Click here to view the
letter.
Buprenorphine
30 Patient Limit Letter (7.29.03)
Available
in .pdf format (click
here for help with .pdf files)
AAAP,
ASAM, APA and AOAAM sent letters to Senators
Hatch, Leahy, Gregg, and Kennedy and
Representatives Tauzin and Dingell expressing
their concern that a provision of the Drug
Addiction Treatment Act of 2000 (DATA, Public Law
106-310) is having the unintended effect of
limiting access of patients to treatment of their
opiate dependence in office-based settings, and to
ask for their assistance in remedying the problem.
AAAP
Responds to the Strategic Plan for
Interdisciplinary Faculty Development (2.24.03)
Prompted
by the release of the "Strategic Plan for
Interdisciplinary Faculty Development: Arming the
Nation’s Health Professional Workforce for a New
Approach to Substance Use Disorders," a
document primarily supported by the Health
Resources and Services Administration (HRSA), the
AAAP reiterates its advocacy of requiring
information about addictions at all levels of
medical education.
Testimony
of AAAP Secretary Dr. Joseph Liberto to the
President's New Freedom Commission on Mental
Health
Testimony
Presented February 5, 2003
AAAP
Board Member Testifies Before the Quality
Treatment Policy Panel During the Demand Treatment
Conference (2.7.03)
Dr.
John T. Pichot, board member of the American
Academy of Addiction Psychiatry (AAAP), testified
at the February 3 Quality Treatment Policy Panel
Hearing, held in conjunction with the Demand
Treatment Conference in Houston, TX. AAAP strongly
supports the leadership of the Quality Treatment
Policy Panel and its efforts to broaden the
public’s understanding of severe alcohol and
drug abuse problems and ways to overcome them.
Testimony
of AAAP Public Policy Section Head Dr. John T.
Pichot at the Quality Treatment Policy Panel
Hearing
Testimony
Presented February 3, 2003
Voluntary
Testing for Drugs Not Mandatory Reporting to Law
Enforcement for Pregnant Women (2.1.03)
The
American Academy of Addiction Psychiatry (AAAP)
joins a friends-of-the-court (amicus) brief in the
Kentucky Court of Appeals hearing in the case of Commonwealth
of Kentucky v. Misti Harris. Ms. Harris was
indicted for child abuse by a Wayne County grand
jury for ingesting OxyContin during pregnancy.
AAAP
President Testifies Before the President's New
Freedom Commission on Mental Health (1.22.03)
Dr.
Richard N. Rosenthal, president of the American
Academy of Addiction Psychiatry (AAAP), testified
at the January 8 meeting of the President’s New
Freedom Commission on Mental Health. AAAP strongly
supports the work of the Commission, especially
its recognition of the importance of considering
the critical needs of those with co-occurring
disorders. In elucidating the dramatic
under-diagnosis and under-treatment of persons
with co-occurring substance use disorders and
mental illness and the effectiveness of integrated
treatments, the Commission underscored the
damaging effects of a system with disparate
training, regulatory and funding support for
mental illness and substance use disorders. These
effects become realities every day to members of
the Academy in their clinical practices.
Testimony
of AAAP President Dr. Richard N. Rosenthal to the
President's New Freedom Commission on Mental
Health
Testimony
Presented January 8, 2003
AAAP
News in Other Publications:
Article
about Dr. Richard N. Rosenthal's Testimony to the
President's New Freedom Commission on Mental
Health on January 8, 2003
New
York State Psychiatric Association Bulletin
Spring
2003 Pages 3-4
Addiction-Treatment
Pioneer Recalls the Early Days
Sheldon
Miller, MD, takes a walk down memory lane and then
peers into the future of addiction psychiatry.
Jim
Rosack, Psychiatric
News January 17, 2003
Comorbidity
Common in Addicts, But Integrated Treatment Rare
For
dual-diagnosis patients, treating both their
mental and addictive disorders simultaneously
poses a challenge. But it may also be their only
hope for recovery.
Jim
Rosack, Psychiatric
News January 17, 2003
MDs
May Needlessly Deny Addicts Opiate-Based Pain
Control
Adequate
and appropriate pain control is often hard enough
to achieve in an otherwise healthy patient.
Achieving pain control in a patient addicted to
opiates is even more difficult and complex.
Jim
Rosack, Psychiatric
News January 17, 2003
Buprenorphine
Archives:
AAAP
Training Courses Become More Significant With FDA
Approval of Buprenorphine (10.9.02)
The
Food and Drug Administration (FDA) approved the
use of buprenorphine for the office-based
treatment of opioid-addicted persons yesterday,
broadening the availability of treatment options
for persons who are reluctant or unable to access
more traditional methadone/LAAM treatment
programs. Qualified physicians may prescribe
Schedule III, IV or V opioid drugs for the
maintenance and detoxification treatment of opioid
addiction from their offices.
AAAP
Launches Web-Based Training Course on Office-Based
Buprenorphine Treatment (6.6.02)
AAAP's
Web-based training course on office-based
buprenorphine treatment is available now!
Buprenorphine
Approval and Waiver Update (4.24.02)
This
letter is in .pdf format. Click
here to get Adobe Acrobat reader.
The
purpose of this letter is to remind you of some of
the basic elements of the legislation, to inform
you of resources available to you, to give you a
preview of what steps still remain and to
encourage you to consider this treatment option
for your opiate dependent patients.
Clinton
Signs Bill Allowing Physicians to Prescribe
Addiction Treatment Medications out of Their
Offices (10.19.00)
Anticipated
Effect is to Significantly Expand Access to
Treatment for Opiate Addiction.
Buprenorphine
Update (Fall 2000)
The
Substance Abuse and Mental Health Services
Administration released a letter September
1, 2000 to clarify the status of
buprenorphine.
Archives:
AAAP
Supports Funding for Developing Clean Needle and
Syringe Programs (7.25.02)
The
American Academy of Addiction Psychiatry (AAAP)
recently revised its policy statement on clean
needle exchange. In order to help eliminate the
reusing and sharing of needle syringes, the AAAP
supports the funding and development of programs
to increase access to clean needles and syringes
for persons who are injection drug users.
Nevada
Voters Decide on Legalization of Marijuana; AAAP
Opposes Such a Measure (7.23.02)
Nevada
voters will decide in November whether to legalize
possession of small amounts of marijuana in that
state. The American Academy of Addiction
Psychiatry (AAAP) continues to oppose legalization
of marijuana, unregulated use of marijuana or use
for medical conditions other than those specified
in the Institute of Medicine report, which
supports the therapeutic value of cannabinoid
drugs for pain relief, control of nausea and
vomiting and appetite stimulation for debilitating
conditions such as AIDS.
AAAP/
AACP Joint Task Force on Public Sector
Interventions for Substance Use Disorders Releases
Continuity of Care Guidelines for Addictions and
Co-Occurring Disorders (7.02)
AAAP
Supports Parity for Mental Illness, Including
Treatment of Substance-Related Disorders (6.18.02)
The
American Academy of Addiction Psychiatry (AAAP)
continues to be a strong supporter of mental
health parity. Passage of parity legislation would
contribute to a reduction in the stigma and bias
associated with mental illness including substance
abuse.
Alcohol
Abuse and Dependence Among U.S. College Students
(6.11.02)
New study from the Harvard School
of Public Health. This link will take you to a
site outside the AAAP Web site.
World
Trade Center Ground Zero: Images from Firefighters
and Iron Workers, Sept. 23-30, 2001
Susanne
Caviness, PhD, Captain, US Public Health Service,
was deployed with the Public Health Service to
establish and staff the field clinics that were
established around the perimeter of the
"Ground Zero" site of the World Trade
Center . Her role was as a mental health
counselor. Some clinics were in tents and some
were in remains of buildings. All were across the
street or around a corner from "the
Pile." The mission was to take care of
injuries of ironworkers and firefighters on site.
AAAP
Announces Affiliate Membership Category (8.4.00)
The
American Academy of Addiction Psychiatry (AAAP) is
pleased to announce its new Affiliate Membership
Category. Affiliate members are defined as
"non-psychiatrist professionals who are
making a contribution to the field of addiction
psychiatry."
|
